Cellosaurus HepG2/TC155 (CVCL_B0UI)
| Cell line name | HepG2/TC155 |
|---|---|
| Accession | CVCL_B0UI |
| Resource Identification Initiative | To cite this cell line use: HepG2/TC155 (RRID:CVCL_B0UI) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013191. Population: Caucasian. Characteristics: Transfected with a hepatitis B virus capsid protein that contains a tetracysteine (TC) C-C-P-G-C-C insertion in position 115. The TC tag specifically reacts with a membrane-permeable biarsenical fluorescent dye (ReAsH) (PubMed=24373334). Genetic integration: Method=Transfection; Gene=UniProtKB; P03146; Hepatitis B virus genotype D subtype ayw capsid protein. Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
| Sequence variations |
|
| Disease | Hepatoblastoma (NCIt: C3728) Hepatoblastoma (ORDO: Orphanet_449) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0027 (Hep-G2) |
| Sex of cell | Male |
| Age at sampling | 15Y |
| Category | Cancer cell line |
| Publications | PubMed=24373334; DOI=10.1111/liv.12419 Patent=CN103667194B |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_B0UI
CCRID; 4201PAT-CCTCC00437 |
| Encyclopedic resources | Wikidata; Q108820460 |
| Entry history | |
| Entry creation | 23-Sep-2021 |
| Last entry update | 27-Nov-2025 |
| Version number | 9 |